Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Beginning Cash Balance (2018 - 2021)

Updated

Skinvisible (SKVI) posted Beginning Cash Balance of $35,896 for Q1 2021, compared with $1,298 a year earlier.

Analysis

Skinvisible (SKVI) Beginning Cash Balance (2018 - 2021) Analysis & Trends

For FY2020, Skinvisible's Beginning Cash Balance came in at $1,298, down 47.7% from FY2019.

  • In prior years, Skinvisible's Beginning Cash Balance was $2,482 in FY2019 (-89.4%) and $23,318 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Skinvisible 1.08 Mn 1.07 Mn 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 35,896.00
Mar 31, 2020 1,298.00
Mar 31, 2019 2,482.00
Mar 31, 2018 23,318.00
API Access

Skinvisible Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=SKVI&period=max&api_key=YOUR_API_KEY